Hims & Hers $HIMS Shares Soared today on the FDA Updates😎 The FDA will be meeting on July 23-24 to review seven different peptides for potential reclassification One of them includes BPC-157, one of the more desired peptides with still an unknown market potential due to

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin